Get An Even Better Deal On RAPT Than Director Robbins Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on July 1, RAPT Therapeutics Inc's Director, Wendye Robbins, invested $67,632.00 into 2,600 shares of RAPT, for a cost per share of $26.01..